Stock Track | Senseonics Soars 5.07% Intraday on Acquisition of Eversense U.S. Assets from Ascensia
Stock Track
Jan 03
Senseonics Holdings Inc. (SENS) saw its stock surge 5.07% during intraday trading on Friday, reflecting strong investor optimism following the company's strategic acquisition announcement.
The medical technology company entered into a Master Asset Purchase Agreement with Ascensia Diabetes Care Holdings AG to acquire U.S. assets related to the marketing, selling, and distribution of the Eversense® continuous glucose monitoring (CGM) system. The deal, which closed on January 1, 2026, also includes plans for Senseonics to expand its footprint in Europe by acquiring additional Eversense-related assets in Italy, Germany, Spain, and Sweden by mid-2026, pending regulatory approvals.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.